Edronax 4 mg tabl.

Valsts: Beļģija

Valoda: angļu

Klimata pārmaiņas: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Aktīvā sastāvdaļa:

Reboxetine Mesilate 5,22 mg - Eq. Reboxetine 4 mg

Pieejams no:

Pfizer SA-NV

ATĶ kods:

N06AX18

SNN (starptautisko nepatentēto nosaukumu):

Reboxetine Mesilate

Deva:

4 mg

Zāļu forma:

Tablet

Kompozīcija:

Reboxetine Mesilate 5.22 mg

Ievadīšanas:

Oral use

Ārstniecības joma:

Reboxetine

Produktu pārskats:

CTI code: 279955-01 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 279955-03 - Pack size: 300 (5 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 279955-02 - Pack size: 180 (3 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 279955-04 - Pack size: 600 (10 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-09 - Pack size: 300 (5 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-04 - Pack size: 60 - Commercialisation status: YES - FMD code: 05415062305546 - CNK code: 1374032 - Delivery mode: Medical prescription; CTI code: 190251-03 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-02 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-08 - Pack size: 180 (3 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-07 - Pack size: 180 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-06 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-05 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 190251-10 - Pack size: 600 (10 x 60) - Commercialisation status: NO - Delivery mode: Medical prescription

Autorizācija statuss:

Commercialised: Yes

Autorizācija datums:

1998-01-16